دورية أكاديمية

Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature

التفاصيل البيبلوغرافية
العنوان: Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature
المؤلفون: Felipe Soto, Luis F. Torre-Sada, Frank E. Mott, Sang T. Kim, Roza Nurieva, Vickie R. Shannon, Saadia A. Faiz, Roberto F. Casal, Mehmet Altan, Julie Lin, Ajay Sheshadri
المصدر: Journal of Immunotherapy and Precision Oncology, Vol 6, Iss 2, Pp 111-116 (2023)
بيانات النشر: Innovative Healthcare Institute, 2023.
سنة النشر: 2023
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: immune checkpoint inhibitor, sarcoidosis, severe asthma, eosinophilia, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Immunologic diseases. Allergy, RC581-607
الوصف: Pulmonary toxicity from immune checkpoint inhibitor therapy is typically a severe and potentially fatal complication, but these observations are driven by the most common toxicity, pneumonitis. Rarer pulmonary immune related adverse events, like airway disease and sarcoidosis, may have a more benign course. In this case report, we present a patient in whom therapy with the PD-1 inhibitor pembrolizumab resulted in severe eosinophilic asthma and sarcoidosis. This is the first case showing that anti–IL-5 inhibition may be safe in patients who develop eosinophilic asthma after ICI therapy. We further show that sarcoidosis does not necessarily require treatment cessation. This case highlights relevant nuances when clinicians face pulmonary toxicities other than pneumonitis.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2666-2345
2590-017X
Relation: https://doaj.org/toc/2666-2345; https://doaj.org/toc/2590-017X
DOI: 10.36401/JIPO-22-30
URL الوصول: https://doaj.org/article/08e33367ec8941b89b5f916d90167269
رقم الأكسشن: edsdoj.08e33367ec8941b89b5f916d90167269
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:26662345
2590017X
DOI:10.36401/JIPO-22-30